DN

DNA Group (T.R.) Ltd.

DNA | TA

Overview

Corporate Details

ISIN(s):
IL0011038523
LEI:
Country:
Israel
Address:
Shimon Hatars' 43, 6249245 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DNA Group develops and markets technological solutions for defense and homeland security sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-06 14:35
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
Hebrew (modern) 149.0 KB
2021-07-29 21:13
Regulatory News Service
Termination of coverage report
Hebrew (modern) 174.5 KB
2021-07-29 21:13
Notice of Dividend Amount
Termination of coverage report
Russian 101.2 KB
2021-06-13 10:10
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
English 1.1 MB
2021-06-13 10:10
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
Russian 101.2 KB
2021-04-11 22:23
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
English 1.1 MB
2021-04-11 22:23
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
Russian 98.1 KB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-09-01 21:58
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-09-01 21:58
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-08-24 21:06
Earnings Release
update analsis (FORST),price target is unchanged
English 1.1 MB
2020-08-24 21:06
Investor Presentation
update analsis (FORST),price target is unchanged
Russian 91.4 KB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
English 1.1 MB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
Russian 93.5 KB

Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.